GSK Investigational Site
Jinzhou 121000
1 studies enrolling now ยท 1 studies all time
What they study most
Pulmonary Disease, Chronic Obstructive
Studies at this site
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
โ Recruiting now